A confirmation of chronic graft-<i>versus</i>-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation.

Pubmed ID: 30655371

Pubmed Central ID: PMC6601098

Journal: Haematologica

Publication Date: July 1, 2019

Affiliation: Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA, USA dmiklos@stanford.edu.

MeSH Terms: Humans, Male, Adult, Female, Aged, Adolescent, Middle Aged, Sex Factors, Young Adult, Child, Prognosis, Follow-Up Studies, Survival Rate, Retrospective Studies, Child, Preschool, Graft vs Host Disease, Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation, Isoantibodies

Grants: U10 HL069294, U24 CA076518, P01 AI056299, P01 CA142106, U24 HL138660, R01 CA183560, R01 CA183559, UG1 HL069290

Authors: Wu J, Howard A, Wang K, Paul J, Nakasone H, Sahaf B, Wu F, Ho V, Kim H, Ritz J, Cutler C, Miklos D, Blazar B

Cite As: Paul J, Nakasone H, Sahaf B, Wu F, Wang K, Ho V, Wu J, Kim H, Blazar B, Ritz J, Howard A, Cutler C, Miklos D. A confirmation of chronic graft-versus-host disease prediction using allogeneic HY antibodies following sex-mismatched hematopoietic cell transplantation. Haematologica 2019 Jul;104(7):e314-e317. Epub 2019 Jan 17.

Studies:

Abstract